Published in J Allergy Clin Immunol on November 01, 2000
Eosinophils contribute to the resolution of lung-allergic responses following repeated allergen challenge. J Allergy Clin Immunol (2014) 1.43
Markers of respiratory inflammation in horses in relation to seasonal changes in air quality in a conventional racing stable. Can J Vet Res (2008) 0.88
Alterations in vasodilator-stimulated phosphoprotein (VASP) phosphorylation: associations with asthmatic phenotype, airway inflammation and beta2-agonist use. Respir Res (2006) 0.82
The role of macrophage IL-10/innate IFN interplay during virus-induced asthma. Rev Med Virol (2014) 0.82
Is low dose inhaled corticosteroid therapy as effective for inflammation and remodeling in asthma? A randomized, parallel group study. Respir Res (2012) 0.81
Cytokine production by peripheral blood CD4+ and CD8+ T cells in atopic childhood asthma. Clin Dev Immunol (2010) 0.79
Dynamics of IL-4 and IL-13 expression in the airways of sheep following allergen challenge. BMC Pulm Med (2015) 0.78
Th2 Cytokine Levels Distort the Association of IL-10 and IFN-γ with Allergic Phenotypes. ISRN Allergy (2011) 0.75
Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med (2000) 9.44
Infection with Mycobacterium avium complex in patients without predisposing conditions. N Engl J Med (1989) 5.79
Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. Asthma Clinical Research Network. N Engl J Med (1996) 4.03
Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol: a randomized controlled trial. JAMA (2001) 3.21
The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma. Am J Respir Crit Care Med (2000) 3.08
Sphingosine 1-phosphate modulates human airway smooth muscle cell functions that promote inflammation and airway remodeling in asthma. FASEB J (2001) 2.15
Effects of colchicine on IgE-mediated early and late airway reactions. Chest (1995) 2.06
A multicenter pilot study of a bronchial valve for the treatment of severe emphysema. Respiration (2009) 1.86
Human lung mast cells: purification and characterization. J Immunol (1982) 1.78
Generation of leukotrienes by purified human lung mast cells. J Clin Invest (1982) 1.77
Predicting worsening asthma control following the common cold. Eur Respir J (2008) 1.70
Regulation of bronchomotor tone by lung inflation in asthmatic and nonasthmatic subjects. J Appl Physiol Respir Environ Exerc Physiol (1981) 1.59
Safety and reproducibility of sputum induction in asthmatic subjects in a multicenter study. Am J Respir Crit Care Med (2001) 1.58
Arachidonic acid metabolism in purified human lung mast cells. J Immunol (1984) 1.47
Nasal challenge with cold, dry air results in release of inflammatory mediators. Possible mast cell involvement. J Clin Invest (1985) 1.45
Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells. J Clin Invest (1983) 1.41
Platelet activation during antigen-induced airway reactions in asthmatic subjects. N Engl J Med (1981) 1.40
Update in pulmonary medicine. Ann Intern Med (1998) 1.39
Effect of deep inspiration on airway conductance in subjects with allergic rhinitis and allergic asthma. J Allergy Clin Immunol (1977) 1.38
Peptide leukotriene release after antigen challenge in patients sensitive to ragweed. N Engl J Med (1984) 1.38
Heterogeneity of human mast cells. J Immunol (1983) 1.37
Differentiation of beta-glucocerebrosidase from beta-glucosidase in human tissues using sodium taurocholate. Arch Biochem Biophys (1976) 1.37
A multicenter registry of patients with acute respiratory distress syndrome. Physiology and outcome. Am Rev Respir Dis (1992) 1.34
Specific interaction of the tetragonally arrayed protein layer of Bacillus sphaericus with its peptidoglycan sacculus. J Bacteriol (1979) 1.34
Lipid bodies: cytoplasmic organelles important to arachidonate metabolism in macrophages and mast cells. J Immunol (1983) 1.33
Effect of ciliostatic factors from Pseudomonas aeruginosa on rabbit respiratory cilia. Infect Immun (1986) 1.30
Characteristics of human basophil sulfidopeptide leukotriene release: releasability defined as the ability of the basophil to respond to dimeric cross-links. J Immunol (1986) 1.28
Airway responses to methacholine in allergic and nonallergic subjects. Am Rev Respir Dis (1976) 1.27
Issues in the use of inhaled glucocorticoids. The Asthma Clinical Research Network. Am J Respir Crit Care Med (1996) 1.25
A microassay for Gaucher's disease. Clin Chim Acta (1975) 1.23
An assessment of the effects of glucocorticoids on degranulation, chemotaxis, binding to vascular endothelium and formation of leukotriene B4 by purified human neutrophils. J Pharmacol Exp Ther (1989) 1.22
Isolation, characterization, and in vitro assembly of the tetragonally arrayed layer of Bacillus sphaericus. J Bacteriol (1979) 1.21
Arrestin specificity for G protein-coupled receptors in human airway smooth muscle. J Biol Chem (2001) 1.20
Effect of polymorphism of the beta(2)-adrenergic receptor on response to regular use of albuterol in asthma. Int Arch Allergy Immunol (2001) 1.18
Purification and properties of a heat-stable glucocerebrosidase activating factor from control and Gaucher spleen. J Biol Chem (1977) 1.16
Dispersed human lung mast cells. Pharmacologic aspects and comparison with human lung tissue fragments. Am Rev Respir Dis (1982) 1.14
Inability of purified Pseudomonas aeruginosa exopolysaccharide to bind selected antibiotics. Antimicrob Agents Chemother (1984) 1.12
Comparative studies of human basophils and mast cells. Fed Proc (1983) 1.11
Isolation of cilia from porcine tracheal epithelium and extraction of dynein arms. Cell Motil Cytoskeleton (1986) 1.10
Airway remodeling and persistent airway obstruction in asthma. J Allergy Clin Immunol (1999) 1.08
Gaucher's disease, a review. Medicine (Baltimore) (1977) 1.08
Differences in the behavior of cytoplasmic granules and lipid bodies during human lung mast cell degranulation. J Cell Biol (1984) 1.07
Absence of changes in airway responsiveness during the menstrual cycle. J Allergy Clin Immunol (1987) 1.03
Isolation and characterization of human intestinal mucosal mast cells. J Immunol (1985) 1.02
Analysis of time course and magnitude of lung inflation effects on airway tone: relation to airway reactivity. Am Rev Respir Dis (1983) 1.01
Characterization of inflammatory mediator release from purified human lung mast cells. Am Rev Respir Dis (1986) 1.01
Protease production by Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Infect Immun (1983) 1.01
Indomethacin modification of immediate-type immunologic airway responses in allergic asthmatic and non-asthmatic subjects: evidence for altered arachidonic acid metabolism in asthma. Am Rev Respir Dis (1981) 0.97
Isolation and characterization of beta-glucosidase from the cytosol of rat kidney cortex. Biochim Biophys Acta (1976) 0.97
Lipoxygenase products modulate histamine release in human basophils. Nature (1981) 0.97
The effect of purified human eosinophil major basic protein on mammalian ciliary activity. Am Rev Respir Dis (1987) 0.96
Pulmonary inflammation after segmental ragweed challenge in allergic asthmatic and nonasthmatic subjects. Am J Respir Crit Care Med (1995) 0.95
Differences in the volume distributions of human lung mast cell granules and lipid bodies: evidence that the size of these organelles is regulated by distinct mechanisms. J Cell Biol (1985) 0.95
Effect of short-term systemic glucocorticoid treatment on human nasal mediator release after antigen challenge. J Clin Invest (1987) 0.95
Kinetics of the development and recovery of the lung from IgE-mediated inflammation: dissociation of pulmonary eosinophilia, lung injury, and eosinophil-active cytokines. Am J Respir Crit Care Med (1997) 0.95
Contributing factors to the pathobiology of asthma. The Th1/Th2 paradigm. Clin Chest Med (2000) 0.95
HLA-DQ strikes again: genome-wide association study further confirms HLA-DQ in the diagnosis of asthma among adults. Clin Exp Allergy (2012) 0.95
Methacholine and physostigmine airway reactivity in asthmatic and nonasthmatic subjects. J Allergy Clin Immunol (1977) 0.94
Local generation of sulfidopeptide leukotrienes upon nasal provocation with cold, dry air. Am Rev Respir Dis (1986) 0.92
sVCAM-1 levels after segmental antigen challenge correlate with eosinophil influx, IL-4 and IL-5 production, and the late phase response. Am J Respir Crit Care Med (1995) 0.92
Characterization of human synovial mast cells. J Rheumatol (1988) 0.92
The pharmacologic modulation of mediator release from human basophils. J Allergy Clin Immunol (1988) 0.92
Immunoglobulin E-mediated degranulation of isolated human lung mast cells. Lab Invest (1985) 0.91
The effect of atropine on acute antigen-mediated airway constriction in subjects with allergic asthma. Am Rev Respir Dis (1977) 0.91
Demonstration of sialyltransferase deficiency in the serum of a patient with alpha-1-antitrypsin deficiency and hepatic cirrhosis. Lab Invest (1974) 0.91
A controlled trial of the effect of the 5-lipoxygenase inhibitor, zileuton, on lung inflammation produced by segmental antigen challenge in human beings. J Allergy Clin Immunol (1996) 0.91
Pulmonary function and gastroesophageal reflux in systemic sclerosis. Ann Intern Med (1994) 0.90
Lung involvement in systemic sclerosis (scleroderma): relation to classification based on extent of skin involvement or autoantibody status. Respir Med (1996) 0.90
HSP27 elevated in mild allergic inflammation protects airway epithelium from H2SO4 effects. Am J Physiol (1997) 0.89
Isolation of heat-stable glucocerebrosidase activators from the spleens of three variants of Gaucher's disease. Arch Biochem Biophys (1977) 0.88
The clinical trials in the initial five-year award period of the Asthma Clinical Research Network. Control Clin Trials (2001) 0.88
Mechanisms of cytokine effects on G protein-coupled receptor-mediated signaling in airway smooth muscle. Am J Physiol Lung Cell Mol Physiol (2001) 0.88
Familial psychosis and diverse neurologic abnormalities in adult-onset Gaucher's disease. Arch Neurol (1979) 0.88
The pharmacologic modulation of the release of arachidonic acid metabolites from purified human lung mast cells. Am Rev Respir Dis (1985) 0.88
Leukotriene B4 as a mediator of early and late reactions to antigen in humans: the effect of systemic glucocorticoid treatment in vivo. J Allergy Clin Immunol (1989) 0.88
Predicting inhaled corticosteroid response in asthma with two associated SNPs. Pharmacogenomics J (2012) 0.87
Pulmonary fibrosis in a patient treated with bumetanide: clinical improvement associated with transition from a granulocytic to lymphocytic alveolitis. Respir Med (1990) 0.87